Ilya Goldshleger - 01 Feb 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
01 Feb 2024
Net transactions value
-$214,230
Form type
4
Filing time
02 Feb 2024, 16:47:53 UTC
Previous filing
22 Jan 2024
Next filing
12 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $123,587 +6,539 +25% $18.90 33,014 01 Feb 2024 Direct
transaction RXST Common Stock Options Exercise $13,594 +590 +1.8% $23.04 33,604 01 Feb 2024 Direct
transaction RXST Common Stock Sale $173,411 -3,539 -11% $49.00 30,065 01 Feb 2024 Direct F1
transaction RXST Common Stock Sale $148,500 -3,000 -10% $49.50 27,065 01 Feb 2024 Direct F1
transaction RXST Common Stock Sale $29,500 -590 -2.2% $50.00 26,475 01 Feb 2024 Direct F1
holding RXST Common Stock 1,372 01 Feb 2024 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -6,539 -45% $0.000000 7,981 01 Feb 2024 Common Stock 6,539 $18.90 Direct
transaction RXST Stock Option (right to buy) Options Exercise $0 -590 -1.9% $0.000000 30,000 01 Feb 2024 Common Stock 590 $23.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2023 by the Reporting Person.